BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 27692879)

  • 1. Drug Repurposing: New Treatments for Zika Virus Infection?
    Cheng F; Murray JL; Rubin DH
    Trends Mol Med; 2016 Nov; 22(11):919-921. PubMed ID: 27692879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing drugs for use against Zika virus infection.
    Devillers J
    SAR QSAR Environ Res; 2018 Feb; 29(2):103-115. PubMed ID: 29299939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for Zika drug discovery.
    Zou J; Shi PY
    Curr Opin Virol; 2019 Apr; 35():19-26. PubMed ID: 30852345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational drugs for the treatment of Zika virus infection: a preclinical and clinical update.
    Han Y; Mesplède T
    Expert Opin Investig Drugs; 2018 Dec; 27(12):951-962. PubMed ID: 30430882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent trends in ZikV research: A step away from cure.
    Alam A; Imam N; Farooqui A; Ali S; Malik MZ; Ishrat R
    Biomed Pharmacother; 2017 Jul; 91():1152-1159. PubMed ID: 28531943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FDA-approved drug sofosbuvir inhibits Zika virus infection.
    Bullard-Feibelman KM; Govero J; Zhu Z; Salazar V; Veselinovic M; Diamond MS; Geiss BJ
    Antiviral Res; 2017 Jan; 137():134-140. PubMed ID: 27902933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The A-Z of Zika drug discovery.
    Mottin M; Borba JVVB; Braga RC; Torres PHM; Martini MC; Proenca-Modena JL; Judice CC; Costa FTM; Ekins S; Perryman AL; Horta Andrade C
    Drug Discov Today; 2018 Nov; 23(11):1833-1847. PubMed ID: 29935345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future and Perspectives of the Zika Virus: Drug Repurposing as a Powerful Tool for Treatment Insights.
    Rampini D; Prieto DC; Colzi AL; de Araújo RV; Giarolla J
    Mini Rev Med Chem; 2020; 20(18):1917-1928. PubMed ID: 32651967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus.
    Saiz JC; Oya NJ; Blázquez AB; Escribano-Romero E; Martín-Acebes MA
    Viruses; 2018 Aug; 10(9):. PubMed ID: 30149598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimalarial drug amodiaquine possesses anti-ZIKA virus activities.
    Han Y; Mesplède T; Xu H; Quan Y; Wainberg MA
    J Med Virol; 2018 May; 90(5):796-802. PubMed ID: 29315671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Inhibitors of ZIKV Replication.
    Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
    Loe MWC; Lee RCH; Chu JJH
    Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in Zika Virus Infection: A Possible Therapeutic Target to Counteract Viral Replication.
    Gratton R; Agrelli A; Tricarico PM; Brandão L; Crovella S
    Int J Mol Sci; 2019 Feb; 20(5):. PubMed ID: 30823365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targets and biological mechanisms of action of curcumin against Zika virus: In silico and in vitro analyses.
    Kim M; Choi H; Kim YB
    Eur J Pharmacol; 2021 Aug; 904():174144. PubMed ID: 33957087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of Doramectin as a New Anti-Zika Virus Agent.
    Zhu Y; Liang M; Yu J; Zhang B; Zhu G; Huang Y; He Z; Yuan J
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection.
    Barrows NJ; Campos RK; Powell ST; Prasanth KR; Schott-Lerner G; Soto-Acosta R; Galarza-Muñoz G; McGrath EL; Urrabaz-Garza R; Gao J; Wu P; Menon R; Saade G; Fernandez-Salas I; Rossi SL; Vasilakis N; Routh A; Bradrick SS; Garcia-Blanco MA
    Cell Host Microbe; 2016 Aug; 20(2):259-70. PubMed ID: 27476412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics.
    McArthur MA
    Viruses; 2017 Jun; 9(6):. PubMed ID: 28608813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.
    Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
    Curr Med Chem; 2021; 28(15):2887-2942. PubMed ID: 32787752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for the Treatment of Zika Virus Infection.
    Bernatchez JA; Tran LT; Li J; Luan Y; Siqueira-Neto JL; Li R
    J Med Chem; 2020 Jan; 63(2):470-489. PubMed ID: 31549836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.